The Measles IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of IgG/IgM antibodies to measles in human whole blood, serum or plasma specimen.
INTENDED USE The Measles IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of IgG/IgM antibodies to measles in human whole blood, serum or plasma specimen.
PRINCIPLE The Measles IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) is a qualitative membranebased immunoassay for the detection of IgG and IgM antibodies to measles in whole blood, serum or plasma specimen. This test consists of two components, an IgG component and an IgM component. In the IgG component, anti-human IgG is coated in IgG test line region. During testing, the specimen reacts with measles antigen-coated particles in the test cassette. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgG in IgG test line region, if the specimen contains IgG antibodies to measles. A colored line will appear in IgG test line region as a result of this. Similarly, antihuman IgM is coated in IgM test line region and if specimen contains IgM antibodies to measles, the conjugate-specimen complex reacts with anti-human IgM. A colored line appears in IgM test line region as a result. Therefore, if the specimen contains measles IgG antibodies, a colored line will appear in IgG test line region. If the specimen contains measles IgM antibodies, a colored line will appear in IgM test line region. If the specimen does not contain measles antibodies, no colored line will appear in either of the test line regions, indicating a negative result. To serve as a procedural control, a colored line will always appear in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred
Product Advantages:
Qualitative Dual-Antibody Detection (lgG/lgM)
Wide Storage Temperature Range(2-30'C,no freezing required)
No cross-reactivity with common related antibodies